Fierce Biotech September 10, 2024
Johnson & Johnson is collating its pantheon of medtech brands under a single banner, to further simplify the company’s presentation.
Going forward, the conglomerate’s Ethicon, DePuy Synthes, Biosense Webster, Abiomed and Cerenovus marques will all operate under the name Johnson & Johnson MedTech. The company said the move will not bring any changes to its various product portfolios.
The rebranding follows updates that J&J made to its marketing one year ago, with the modernization of its decades-old cursive emblem into a new logo, alongside the announcement of the planned renaming of its Janssen pharmaceutical group to Johnson & Johnson Innovative Medicine.
Prior to that, in early 2022, the company simplified its references to “the medical device companies of Johnson &...
Today's Sponsors
Today's Sponsor